Jeena Sikho Lifecare Quarterly Results for Trading Insights
JSLL • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹59 Cr
QSept 2025
Jeena Sikho Lifecare Quarterly Results Key Highlights
- Revenue of ₹191 Cr in Sept 2025 (+36.4% vs Mar 2025, +61.9% vs Sept 2024)
- Net Profit of ₹59 Cr in Sept 2025 (+136.0% vs Mar 2025, +118.5% vs Sept 2024)
- EBITDA of ₹94 Cr in Sept 2025 (+104.3% vs Mar 2025)
- Operating Margin of 48.0% in Sept 2025 (+15.0pp vs Mar 2025)
- Earnings Per Share of ₹4.73 in Sept 2025 (+131.9% vs Mar 2025)
Jeena Sikho Lifecare Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 191 | 140 | 175 | 224 | 118 | 36.4% | 61.9% |
| Net Profit (₹ Cr) | 59 | 25 | 51 | 67 | 27 | - | - |
| EBITDA (₹ Cr) | 94 | 46 | 80 | 103 | 44 | - | - |
| EPS (₹) | 4.73 | 2.04 | 4.12 | 5.36 | 2.14 | - | - |
| Operating Margin (%) | 48.0% | 33.0% | 45.0% | 45.0% | 35.0% | - | - |
Jeena Sikho Lifecare Share Price Trend Around Quarterly Results
Visualize Jeena Sikho Lifecare's 1-year price movement across quarterly results — ideal for logging trades in Jeena Sikho Lifecare share price
chart using Tickjournal. All values in ₹.
Related Pages for Jeena Sikho Lifecare
Additional stock information and data for JSLL
Revenue Trend (₹ Cr)
Dec 2025
224
Jun 2025
175
Mar 2025
140
Sept 2025
191
Net Profit Trend (₹ Cr)
Dec 2025
67
Jun 2025
51
Mar 2025
25
Sept 2025
59
Operating Margin Trend (%)
Dec 2025
45.0%
Jun 2025
45.0%
Mar 2025
33.0%
Sept 2025
48.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Jeena Sikho Lifecare quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹416,764.48 Cr | 1752.5 | 14,875 | 3,125 | +10.8% | - | 21.0% | 134.8 |
|
Divis Laboratories
Sept 2025 |
₹170,125.54 Cr | 6403.5 | 2,860 | 689 | +7.1% | - | 24.1% | 246.6 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹146,658.56 Cr | 4369.2 | 3,219 | 591 | +11.3% | - | 18.4% | 249.1 |
|
Cipla
Sept 2025 |
₹109,178.44 Cr | 1351.6 | 7,716 | 1,353 | +12.0% | - | 17.5% | 80.8 |
|
Dr Reddys Laborator…
Sept 2025 |
₹107,358.50 Cr | 1294.4 | 9,135 | 1,337 | +1.1% | - | 14.6% | 80.0 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores